Voltar
Artigo Revisado por pares
BIBTEX RIS

Proton Pump Inhibitor Use and Bone Health in Patients With Rheumatic Diseases: A Cross-Sectional Study

2024; Elsevier BV; Volume: 99; Issue: 7 Linguagem: Inglês

10.1016/j.mayocp.2023.12.008

ISSN

1942-5546

Autores

Andriko Palmowski, Gabriela Schmajuk, Jinoos Yazdany, Patricia Katz, Jing Li, Rachael Stovall, Emma Kersey, Sabrina Mai Nielsen, Robin Christensen, Henning Bliddal, Zhivana Boyadzhieva, Udo Schneider, Tobias Alexander, Burkhard Muche, Sandra Hermann, Edgar Wiebe, Frank Buttgereit,

Tópico(s)

Hip disorders and treatments

Resumo

To assess the effect of proton pump inhibitor (PPI) use on bone mineral density (BMD) and bone microarchitecture as measured by the trabecular bone score (TBS) in patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs).

Referência(s)